The fabrication of hydroxyapatite (HAP)/MgO composite coatings on Mg alloy is crucial for enhancing the corrosion resistance and biocompatibility of biomedical implants. In this study, we aimed to investigate the effects of two different surface modification methods, i.e., electrochemical (electrodeposition, ED) and chemical (solution treatment, ST), on the phase structure, degradation properties, and biocompatibility of the composite coatings in comparison to the anodized coating. The surface morphologies and crystalline structures of the coatings were characterized by scanning electron microscopy (SEM) and X-ray diffraction (XRD). Subsequently, the degradation rate of the coatings in simulated body fluid were comprehensively evaluated by using electrochemical impedance spectroscopy (EIS), potentiodynamic polarization and scanning electrochemical microscopy (SECM) tests. Additionally, in-vitro cell proliferation assays were employed to quantitatively assess the biocompatibilities of the coatings. The results showed that both ED and ST methods were effective in depositing HAP on anodized Mg alloy, resulting in different surface morphologies with hydroxyapatite layer thicknesses of 2.71 μm and 3.56 μm, respectively. In this way, the HAP-deposited coatings exhibited improved corrosion resistances and biocompatibilities compared with those of the anodized coating. Specifically, the ST-deposited composite film displayed superior degradability and biocompatibility which was attributed to its filiform surface morphology and thicker HAP layer. Overall, the present study demonstrates the potential of HAP/MgO composite coatings for biomedical applications, with implications for the development of advanced implant materials with improved performance and biocompatibility.
Read full abstract